- IBDEI2JG ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,40533,1,4,0)
- ;;=4^R63.3
- ;;^UTILITY(U,$J,358.3,40533,2)
- ;;=^5019541
- ;;^UTILITY(U,$J,358.3,40534,0)
- ;;=R63.4^^152^2012^33
- ;;^UTILITY(U,$J,358.3,40534,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40534,1,3,0)
- ;;=3^Abnormal Weight Loss
- ;;^UTILITY(U,$J,358.3,40534,1,4,0)
- ;;=4^R63.4
- ;;^UTILITY(U,$J,358.3,40534,2)
- ;;=^5019542
- ;;^UTILITY(U,$J,358.3,40535,0)
- ;;=R63.5^^152^2012^32
- ;;^UTILITY(U,$J,358.3,40535,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40535,1,3,0)
- ;;=3^Abnormal Weight Gain
- ;;^UTILITY(U,$J,358.3,40535,1,4,0)
- ;;=4^R63.5
- ;;^UTILITY(U,$J,358.3,40535,2)
- ;;=^5019543
- ;;^UTILITY(U,$J,358.3,40536,0)
- ;;=R64.^^152^2012^50
- ;;^UTILITY(U,$J,358.3,40536,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40536,1,3,0)
- ;;=3^Cachexia
- ;;^UTILITY(U,$J,358.3,40536,1,4,0)
- ;;=4^R64.
- ;;^UTILITY(U,$J,358.3,40536,2)
- ;;=^17920
- ;;^UTILITY(U,$J,358.3,40537,0)
- ;;=R68.3^^152^2012^55
- ;;^UTILITY(U,$J,358.3,40537,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40537,1,3,0)
- ;;=3^Clubbing of Fingers
- ;;^UTILITY(U,$J,358.3,40537,1,4,0)
- ;;=4^R68.3
- ;;^UTILITY(U,$J,358.3,40537,2)
- ;;=^5019553
- ;;^UTILITY(U,$J,358.3,40538,0)
- ;;=R73.01^^152^2012^94
- ;;^UTILITY(U,$J,358.3,40538,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40538,1,3,0)
- ;;=3^Impaired Fasting Glucose
- ;;^UTILITY(U,$J,358.3,40538,1,4,0)
- ;;=4^R73.01
- ;;^UTILITY(U,$J,358.3,40538,2)
- ;;=^5019561
- ;;^UTILITY(U,$J,358.3,40539,0)
- ;;=R73.02^^152^2012^95
- ;;^UTILITY(U,$J,358.3,40539,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40539,1,3,0)
- ;;=3^Impaired Glucose Tolerance (oral)
- ;;^UTILITY(U,$J,358.3,40539,1,4,0)
- ;;=4^R73.02
- ;;^UTILITY(U,$J,358.3,40539,2)
- ;;=^5019562
- ;;^UTILITY(U,$J,358.3,40540,0)
- ;;=R73.09^^152^2012^18
- ;;^UTILITY(U,$J,358.3,40540,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40540,1,3,0)
- ;;=3^Abnormal Glucose NEC
- ;;^UTILITY(U,$J,358.3,40540,1,4,0)
- ;;=4^R73.09
- ;;^UTILITY(U,$J,358.3,40540,2)
- ;;=^5019563
- ;;^UTILITY(U,$J,358.3,40541,0)
- ;;=R73.9^^152^2012^89
- ;;^UTILITY(U,$J,358.3,40541,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40541,1,3,0)
- ;;=3^Hyperglycemia,Unspec
- ;;^UTILITY(U,$J,358.3,40541,1,4,0)
- ;;=4^R73.9
- ;;^UTILITY(U,$J,358.3,40541,2)
- ;;=^5019564
- ;;^UTILITY(U,$J,358.3,40542,0)
- ;;=R76.11^^152^2012^147
- ;;^UTILITY(U,$J,358.3,40542,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40542,1,3,0)
- ;;=3^Positive PPD
- ;;^UTILITY(U,$J,358.3,40542,1,4,0)
- ;;=4^R76.11
- ;;^UTILITY(U,$J,358.3,40542,2)
- ;;=^5019570
- ;;^UTILITY(U,$J,358.3,40543,0)
- ;;=R79.1^^152^2012^3
- ;;^UTILITY(U,$J,358.3,40543,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40543,1,3,0)
- ;;=3^Abnormal Coagulation Profile
- ;;^UTILITY(U,$J,358.3,40543,1,4,0)
- ;;=4^R79.1
- ;;^UTILITY(U,$J,358.3,40543,2)
- ;;=^5019591
- ;;^UTILITY(U,$J,358.3,40544,0)
- ;;=R82.5^^152^2012^74
- ;;^UTILITY(U,$J,358.3,40544,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40544,1,3,0)
- ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
- ;;^UTILITY(U,$J,358.3,40544,1,4,0)
- ;;=4^R82.5
- ;;^UTILITY(U,$J,358.3,40544,2)
- ;;=^5019605
- ;;^UTILITY(U,$J,358.3,40545,0)
- ;;=R82.6^^152^2012^30
- ;;^UTILITY(U,$J,358.3,40545,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,40545,1,3,0)
- ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
- ;;^UTILITY(U,$J,358.3,40545,1,4,0)
- ;;=4^R82.6
- ;;^UTILITY(U,$J,358.3,40545,2)
- ;;=^5019606
- ;;^UTILITY(U,$J,358.3,40546,0)
- ;;=R82.90^^152^2012^29
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2JG 3747 printed Feb 18, 2025@23:56:22 Page 2
- IBDEI2JG ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,40533,1,4,0)
- +2 ;;=4^R63.3
- +3 ;;^UTILITY(U,$J,358.3,40533,2)
- +4 ;;=^5019541
- +5 ;;^UTILITY(U,$J,358.3,40534,0)
- +6 ;;=R63.4^^152^2012^33
- +7 ;;^UTILITY(U,$J,358.3,40534,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,40534,1,3,0)
- +10 ;;=3^Abnormal Weight Loss
- +11 ;;^UTILITY(U,$J,358.3,40534,1,4,0)
- +12 ;;=4^R63.4
- +13 ;;^UTILITY(U,$J,358.3,40534,2)
- +14 ;;=^5019542
- +15 ;;^UTILITY(U,$J,358.3,40535,0)
- +16 ;;=R63.5^^152^2012^32
- +17 ;;^UTILITY(U,$J,358.3,40535,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,40535,1,3,0)
- +20 ;;=3^Abnormal Weight Gain
- +21 ;;^UTILITY(U,$J,358.3,40535,1,4,0)
- +22 ;;=4^R63.5
- +23 ;;^UTILITY(U,$J,358.3,40535,2)
- +24 ;;=^5019543
- +25 ;;^UTILITY(U,$J,358.3,40536,0)
- +26 ;;=R64.^^152^2012^50
- +27 ;;^UTILITY(U,$J,358.3,40536,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,40536,1,3,0)
- +30 ;;=3^Cachexia
- +31 ;;^UTILITY(U,$J,358.3,40536,1,4,0)
- +32 ;;=4^R64.
- +33 ;;^UTILITY(U,$J,358.3,40536,2)
- +34 ;;=^17920
- +35 ;;^UTILITY(U,$J,358.3,40537,0)
- +36 ;;=R68.3^^152^2012^55
- +37 ;;^UTILITY(U,$J,358.3,40537,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,40537,1,3,0)
- +40 ;;=3^Clubbing of Fingers
- +41 ;;^UTILITY(U,$J,358.3,40537,1,4,0)
- +42 ;;=4^R68.3
- +43 ;;^UTILITY(U,$J,358.3,40537,2)
- +44 ;;=^5019553
- +45 ;;^UTILITY(U,$J,358.3,40538,0)
- +46 ;;=R73.01^^152^2012^94
- +47 ;;^UTILITY(U,$J,358.3,40538,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,40538,1,3,0)
- +50 ;;=3^Impaired Fasting Glucose
- +51 ;;^UTILITY(U,$J,358.3,40538,1,4,0)
- +52 ;;=4^R73.01
- +53 ;;^UTILITY(U,$J,358.3,40538,2)
- +54 ;;=^5019561
- +55 ;;^UTILITY(U,$J,358.3,40539,0)
- +56 ;;=R73.02^^152^2012^95
- +57 ;;^UTILITY(U,$J,358.3,40539,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,40539,1,3,0)
- +60 ;;=3^Impaired Glucose Tolerance (oral)
- +61 ;;^UTILITY(U,$J,358.3,40539,1,4,0)
- +62 ;;=4^R73.02
- +63 ;;^UTILITY(U,$J,358.3,40539,2)
- +64 ;;=^5019562
- +65 ;;^UTILITY(U,$J,358.3,40540,0)
- +66 ;;=R73.09^^152^2012^18
- +67 ;;^UTILITY(U,$J,358.3,40540,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,40540,1,3,0)
- +70 ;;=3^Abnormal Glucose NEC
- +71 ;;^UTILITY(U,$J,358.3,40540,1,4,0)
- +72 ;;=4^R73.09
- +73 ;;^UTILITY(U,$J,358.3,40540,2)
- +74 ;;=^5019563
- +75 ;;^UTILITY(U,$J,358.3,40541,0)
- +76 ;;=R73.9^^152^2012^89
- +77 ;;^UTILITY(U,$J,358.3,40541,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,40541,1,3,0)
- +80 ;;=3^Hyperglycemia,Unspec
- +81 ;;^UTILITY(U,$J,358.3,40541,1,4,0)
- +82 ;;=4^R73.9
- +83 ;;^UTILITY(U,$J,358.3,40541,2)
- +84 ;;=^5019564
- +85 ;;^UTILITY(U,$J,358.3,40542,0)
- +86 ;;=R76.11^^152^2012^147
- +87 ;;^UTILITY(U,$J,358.3,40542,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,40542,1,3,0)
- +90 ;;=3^Positive PPD
- +91 ;;^UTILITY(U,$J,358.3,40542,1,4,0)
- +92 ;;=4^R76.11
- +93 ;;^UTILITY(U,$J,358.3,40542,2)
- +94 ;;=^5019570
- +95 ;;^UTILITY(U,$J,358.3,40543,0)
- +96 ;;=R79.1^^152^2012^3
- +97 ;;^UTILITY(U,$J,358.3,40543,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,40543,1,3,0)
- +100 ;;=3^Abnormal Coagulation Profile
- +101 ;;^UTILITY(U,$J,358.3,40543,1,4,0)
- +102 ;;=4^R79.1
- +103 ;;^UTILITY(U,$J,358.3,40543,2)
- +104 ;;=^5019591
- +105 ;;^UTILITY(U,$J,358.3,40544,0)
- +106 ;;=R82.5^^152^2012^74
- +107 ;;^UTILITY(U,$J,358.3,40544,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,40544,1,3,0)
- +110 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
- +111 ;;^UTILITY(U,$J,358.3,40544,1,4,0)
- +112 ;;=4^R82.5
- +113 ;;^UTILITY(U,$J,358.3,40544,2)
- +114 ;;=^5019605
- +115 ;;^UTILITY(U,$J,358.3,40545,0)
- +116 ;;=R82.6^^152^2012^30
- +117 ;;^UTILITY(U,$J,358.3,40545,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,40545,1,3,0)
- +120 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
- +121 ;;^UTILITY(U,$J,358.3,40545,1,4,0)
- +122 ;;=4^R82.6
- +123 ;;^UTILITY(U,$J,358.3,40545,2)
- +124 ;;=^5019606
- +125 ;;^UTILITY(U,$J,358.3,40546,0)
- +126 ;;=R82.90^^152^2012^29
